Clinical Trials Directory

Trials / Unknown

UnknownNCT00764218

Cardiovascular Phenotype Study in Patients With Obstructive Sleep Apnea Syndrome

Cardiovascular Phenotype Study in Patients With Obstructive Sleep Apnea Syndrome : Role of Hypertension

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Patients with obstructive sleep apnea syndrome have permanent variations of their hemodynamic parameters during the night : heart rate, arterial blood pressure, cardiac output. This is due to the repetition of respiratory events (obstructive apnea and hypopnea) leading to frequent micro-arousals. These disorders have several consequences : hypertension, NO-dependent vasodilatation impairment, baroreceptor reflex impairment, insulin resistance and other cardiovascular impairments.

Detailed description

Objective of the study is to characterize the cardiovascular phenotype of patients with obstructive sleep apnea syndrome, relative to the presence of hypertension or not. Hypertension should not have been previously treated. 2 groups of apneic patients (SAS+HTA+ and SAS+HTA-) will be compared together, referred to group of non apneic but hypertensive patients (SAS-HTA+) and non apneic / non hypertensive patients (SAS-HTA-). Apneic and hypertensive patients may have a sympathetic nervous system activation and a much more important vascular and baroreceptor reflex impairment, than non apneic but hypertensive patients. During the study, a second visit as control will be done for apneic patients only, 3 to 6 months after SAS treatment setting.

Conditions

Interventions

TypeNameDescription
DEVICEPositive airway pressure treatmentPositive airway pressure treatment as long as necessary
OTHERNo positive airway pressure treatmentNo treatment

Timeline

Start date
2001-03-01
Primary completion
2003-12-01
Completion
2008-12-01
First posted
2008-10-01
Last updated
2008-10-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00764218. Inclusion in this directory is not an endorsement.